<DOC>
	<DOCNO>NCT02113423</DOCNO>
	<brief_summary>The hypothesis study address efficacy toxicity profile aforementioned four modality rT1-2 NPC . Characters patient : - list item one : 168 patient , median age 48 year ( range 16-75 years） proven rT1-2 NPC diagnose - list item two : Treated four different irradiation modality ( 3D-CRT , IMRT , BT , BT Combined 3D-CRT IMRT ) . - list item three : Median time recurrence 30 month ( range 1-180months ) . The median follow-up time 28 month ( range , 4-135 month ) .</brief_summary>
	<brief_title>Intensity Modulated Radiotherapy Recurrent T1-2 Nasopharyngeal Carcinoma</brief_title>
	<detailed_description>Objectives : Recurrent T1-2 Nasopharyngeal Carcinoma ( rT1-2 ) may salvage 3D - CRT（3D-Conformal Radiotherapy） , IMRT（ Intensity Modulated Radiotherapy） , Brachytherapy ( BT ) , BT combine 3D - CRT IMRT . The aim study address efficacy toxicity profile aforementioned four modality rT1-2 NPC . Methods Materials : 168 patient , median age 48 year ( range 16-75 years） proven rT1-2 NPC diagnose treated four different irradiation modality ( 3D-CRT , IMRT , BT , BT Combined 3D-CRT IMRT ) . Median time recurrence 30 month ( range 1-180months ) . The median follow-up time 28 month ( range , 4-135 month ) .</detailed_description>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>recurrent T12 nasopharyngeal carcinoma patient non recurrent T12 nasopharyngeal carcinoma patient</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>superiority , re-irradiation , IMRT , recurrent T1-2 NPC</keyword>
</DOC>